What is the recommended dose of cholestyramine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cholestyramine Dosing Recommendations

The recommended starting dose of cholestyramine is 4 grams (one packet or scoop) once or twice daily, with a maintenance dose of 8-16 grams daily divided into two doses, and a maximum dose of 24 grams daily. 1

Standard Dosing Regimen

  • Starting dose: 4 grams (one packet/scoop) once or twice daily 1
  • Maintenance dose: 8-16 grams daily, divided into two doses 1
  • Maximum dose: 24 grams daily (six packets/scoops) 1
  • Dose titration: Increases should be gradual with lipid assessment at intervals of at least 4 weeks 1

Dosing Frequency Options

Cholestyramine can be administered flexibly from once daily to six times daily, though twice-daily dosing is the standard recommendation. 1

  • Twice-daily administration is equally effective as four-times-daily dosing for the same total daily dose 2
  • Single daily dosing of 12-16 grams achieves comparable cholesterol reduction to traditional three-times-daily regimens (21.58% vs 25.61% reduction) 3
  • For doses of 24 grams daily, twice-daily administration is more practical due to volume considerations 3

Optimal Timing of Administration

The evening dose should be taken 30 minutes before the evening meal for maximum LDL-cholesterol reduction. 4

  • Taking the p.m. dose 30 minutes before the evening meal produces significantly greater cholesterol reduction compared to mid-afternoon administration 4
  • The suggested administration time is at mealtime, though this can be modified to avoid interference with other medications 1

Special Population Dosing

Chronic Kidney Disease

  • No dosage adjustment is needed in CKD patients 5

Pruritus in Sclerosing Cholangitis

  • Cholestyramine is not recommended as first-line therapy for pruritus in sclerosing cholangitis due to limited evidence and potential interference with UDCA absorption 5
  • Bezafibrate or rifampicin are preferred for moderate to severe pruritus in this population 5

Hyperthyroidism (Adjunctive Therapy)

  • Lower doses of 2-4 grams twice daily (4-8 grams total) are often effective and better tolerated as adjunctive therapy 6

Administration Guidelines

Always mix cholestyramine powder with at least 2-3 ounces of water or non-carbonated beverage; never take in dry form. 1

  • Can be mixed with highly fluid soups or pulpy fruits like applesauce or crushed pineapple 1
  • Critical drug interaction timing: Other medications must be taken at least 1 hour before or 4 hours after cholestyramine to avoid impaired absorption 1, 6
  • High-risk medications requiring separation include thyroid hormones, warfarin, oral contraceptives, cyclosporine, phenytoin, and sulfonylureas 7

Expected Efficacy by Dose

The dose-response relationship for LDL-cholesterol reduction is well-established:

  • 8 grams daily: Approximately 16-22% LDL-C reduction 7
  • 16 grams daily: Approximately 23-27% LDL-C reduction 7, 3
  • 24 grams daily: Approximately 27-28% LDL-C reduction 7, 3

Important Safety Considerations

Contraindications

  • Complete biliary obstruction 1, 6
  • History of serious hypersensitivity to cholestyramine 1, 6

Common Adverse Effects

  • Gastrointestinal symptoms (constipation, dyspepsia, nausea) are most common 6, 1
  • May increase triglyceride levels 6, 3
  • Gradual titration minimizes GI side effects 1

Nutritional Monitoring with Long-Term Use

  • Folate deficiency develops with prolonged treatment; oral folic acid 5 mg daily should be given to all patients on long-term therapy 8
  • Fat-soluble vitamins (A, E, K) may decrease but typically remain in normal range 8
  • Monitor prothrombin time and fat-soluble vitamin levels periodically 8
  • Vitamin K deficiency can occur; oral vitamins should be administered at least 4 hours before cholestyramine 7

Special Warnings

  • May increase TSH in patients receiving thyroid hormone replacement therapy 6
  • Post-marketing reports include bowel obstruction, esophageal obstruction, and fecal impaction 6

Clinical Pearls

  • Cholestyramine is safe during pregnancy and lactation as it is not systemically absorbed 7
  • The color of powder may vary between batches without affecting efficacy 1
  • Combining cholestyramine with HMG-CoA reductase inhibitors produces additive LDL-cholesterol lowering effects 1

References

Research

Cholestyramine: an effective, twice-daily dosage regimen.

Annals of internal medicine, 1976

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cholestyramine Dosing and Administration in Hyperthyroidism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colestipol Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.